false
OasisLMS
English
Skip Navigation Links
Publications
JTO
CRR
ILCN
Menu
Publications
JTO
CRR
ILCN
Hamburger Menu
Catalog
Treating EGFR Mutant NSCLC in Brazil
Treating EGFR Mutant NSCLC in Brazil
Podcast | English | 2023 | 38 Min
Create Account
Credit
No Credit Offered
IASLC Lung Cancer Considered Podcast
This episode of Lung Cancer Considered examines the treatment of EGFR-positive lung cancer in Brazil from early-stage disease to metastatic lung cancer.
Faculty
Host:
Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, USA
Guests:
Victor Marcondes, MD, Thoracic Medical Oncologist, Oncomed Oncologia, Brazil
Juliana Ominelli, MD, medical Oncologist, Brazilian National Cancer Institute - Oncologia DASA, Brazil
×
Treating EGFR Mutant NSCLC in Brazil Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English
12
Russian